Research Article
Assessment of Relative Percentage Change in Clinical Parameters and Systemic Levels of Rbc-Sod, Gpx and Vitamin-C in Patients with Chronic Periodontitis After Scaling and Root Planning
Abdul Samad Aziz*, Rahul Kale, Madhav Govind Kalekar and Adinath Narayan Suryakar
Corresponding Author: Abdul Samad Aziz, Department of Biochemistry, MA. Rangoonwala College of Dental Sciences and Research Centre, Pune 411001, India
Received: July 03, 2020; Revised: July 14, 2020; Accepted: July 14, 2020 Available Online: December 08, 2020
Citation: Aziz AS, Kale R, Kalekar MG & Suryakar AN. (2021). Assessment of Relative Percentage Change in Clinical Parameters and Systemic Levels of Rbc-Sod, Gpx and Vitamin-C in Patients with Chronic Periodontitis After Scaling and Root Planning. BioMed Res J, 5(1): 322-327.
Copyrights: ©2021 Aziz AS, Kale R, Kalekar MG & Suryakar AN. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 2999

    Views & Citations
  • 1999

    Likes & Shares
Introduction and background: Periodontitis, an inflammatory disorder of the periodontium, has been associated with oxidative stress (OS). Recent studies have linked an abnormal OS burden in individuals with periodontitis. Dental professionals employ scaling and root planning (SRP) therapy to treat this disorder. Scarcity of literature associating the quantification of effects of SRP on periodontal parameters and systemic biochemical OS markers has provoked us to take up this study.

Aims and Objectives: To quantify the SRP therapy outcome as relative percentage change and gauge the association in the improvements in clinical parameters to those of biochemical OS markers.

Methodology: Individuals with chronic periodontitis were clinically and biochemically evaluated. SRP therapy was performed and a follow-up was done after 3 months. The mean values of study parameters were subjected to statistical analysis.

Results: Individuals with chronic periodontitis showed altered clinical and biochemical OS markers. After SRP, both clinical and biochemical parameters showed significant (p˂0.05) differential improvements from their corresponding pre-treatment values. When the relative percentage was assessed, the improvements in clinical parameters were higher than that of biochemical parameters. Further the relative % change in clinical parameters showed weak correlation to that of biochemical parameters.

Conclusion: The SRP is beneficial for individuals with periodontitis. Further the improvement in clinical parameters is accompanied by improvement in biochemical OS parameters.

Keywords: Chronic periodontitis, Oxidative stress, Biochemical markers, Scaling and root planning, Relative percentage change
Chronic periodontitis (CP) is an inflammatory disorder of the periodontium, which affects the supportive tissue of the teeth [1]. Oxidative stress (OS) has been related to the onset and or progression of growing number of human diseases [2], including periodontitis [3]. OS has been linked with both, onset of periodontal tissue destruction and progression of CP [4,5]. The role of reactive oxygen species (ROS), antioxidant (AO) systems and the products of OS play an important role in the pathology of periodontitis [1].

Scaling and root planning (SRP) is the phase I periodontal therapy and has been employed in controlling CP [6]. This therapy has yielded beneficial effect on clinical parameters like prolong depth (PD), clinical attachment level (CAL) [6], and healthy outcomes in the levels of biochemical markers like; 1L-1β, TNF-α, hsCRP, E-selectin etc. [7,8]. The bidirectional relationship between CP and OS is established [9]. The CP affects the OS status in the individuals and controlling the CP through the application of SRP has beneficial outcomes in OS markers [10,11]. Therefore, the present study was planned to quantify the association of the extent of improvement in clinical parameters to those of some systemic AO markers.


Study groups
Group I (C): Individuals with slight chronic periodontitis (CAL˂3 mm); n=120 (males=65, females=55), Mean age= 38.51±5.55 comprises the control group. They were apparently healthy with good oral and systemic health and have not reported any habits, any illness needing medication and/or hospitalization in the last six months. They were clinically evaluated only once, and their blood sample was collected and analyzed only once.

Group II (CP): Individuals with severe chronic periodontitis (CAL≥3 mm); n= 86 (males=51, females=35), Mean age= 40.9±4.61 formed this group. The subjects in this group were otherwise healthy, with no history of major illness and consumption of antioxidants, antibiotics, anti-inflammatory or any other drugs and had not received any periodontal therapy for at least 6 months prior to the inception of the study. Individuals having past illness and undergoing any treatment, diabetics and alcoholics were excluded from the study. This group has received SRP therapy and a follow-up was done after 3 months.

Clinical Measurements

The individuals in both the study groups were clinically evaluated for chronic periodontitis according to the criteria of the American Academy of Periodontology (1999) [12]. The periodontal status of all individuals was evaluated by measurement of gingival index (GI) [13], plaque index (PI) [14], probing depth (PD) and clinical attachment level (CAL). The PD and CAL measurements were done as prescribed [12,15]. All clinical measurements were evaluated using University of North Carolina (UNC-15) probe (Hu-Friedy, Chicago).

Sample Collection

A total of 4 ml venous blood was collected in disposable syringe from all the subjects following standard precautionary measures. Of this 2 ml blood was used for analysis of RBC-SOD (Superoxide Dismutase) and GPx (Glutathione Peroxidase) and the remaining 2 ml was allowed to stand at room temperature for 30 min and centrifuged at 3,000 rpm for 20 min to obtain serum, which was stored at −4 °C until further analysis of vitamin C. All the biochemical markers were measured on calibrated semi auto analyser BIOTRON BTR-830 (Ranbaxy laboratories, India). The blood samples were collected twice once at baseline (C and CP group) and then after 3 months of SRP therapy (CP group).

Biochemical studies

RBC-SOD and GPx: The RBC-SOD and GPx were measured using RANSOD and RANSEL kits (Randox Laboratotries, UK) respectively following the manufacturer’s instructions [16,17].

Vitamin C: The serum vitamin C content was measured using the dinitro-phenyl hydrazine (DNPH) method. Briefly, in strong acidic medium, vitamin C is oxidized to diketogluonic acid which reacts with 2,4 DNPH to form diphenylhydrazone which dissolves in strong sulphuric acid solution to produce a red colored complex which was measured at 500 nm [18].

SRP therapy: The participants in group CP received periodontal therapy, which included SRP and oral hygiene instructions. The SRP was performed by qualified periodontologist using ultrasonic instrument (Electro Medical System, Switzerland) and manual Gracey curettes (Hu-Friedy, Avco). The instructions for oral hygiene included demonstration of Bass technique of brushing [19] and instruction to brush twice daily after meals. Post SRP therapy a follow up was done after 3 months.

Relative % change calculation: Relative % change is calculated using the formula-Negative value indicates post treatment higher value and vice versa.

Statistical Analysis: The statistical analysis for study parameters was done using Statistical Package for Social Sciences (IBM-SPSS version 19) for MS Windows. The values were expressed as mean ± SD across the study groups. The independent sample t test was employed for the comparison of significance of difference of mean values. The correlation of relative % change in clinical and biochemical parameters was assessed using two tailed Pearson correlation tests. P value < 0.05 is considered to be statistically significant.


The obtained values indicate a significantly higher (p < 0.001) mean values of clinical parameters and level of RBC-SOD in individuals belonging to CP than C group. The mean values of GPx and vitamin C were significantly lowered (p < 0.001) in individuals of CP than those of C group (Table 1).

Furthermore, the results (Table 2) showed a statistically significant difference (p < 0.001) in the post treatment mean values of clinical and biochemical parameters compared to their corresponding baseline (pre-treatment) values for individuals of CP group. Table 3 represents the mean relative % change in the clinical and biochemical parameters in CP group. Among the biochemical markers GPx and vitamin C showed significant (p˂0.05) negative correlation to PI, PD and GI respectively (Table 4).

The present study attempts to understand and probably quantify the relationship between the extent of improvement in clinical periodontal parameters and systemic AO marker after SRP therapy. The result of this study demonstrated that the individuals in CP group showed higher clinical damage and altered systemic AO markers then those of individuals in C group (Table 1). SRP was beneficial in improving clinical as well as biochemical markers in CP group (Table 2). Furthermore, the relative percentage change in clinical parameters showed some correlation with systemic AO markers (Table 4) although it couldn’t reach statistical significance for all the parameters.

Oxidative stress (OS) has been linked with both onset of periodontal tissue destruction and systemic inflammation [4] with increased ROS concentration leading to oxidative damage and an impaired circulating oxidant: antioxidant balance [20,21]. All mammalian cells contain antioxidants (Enzymes, other proteins, metabolites and vitamins) that prevent or limit oxidative tissue injury caused by ROS [3].

The findings related to the pre and a post-treatment change in RBC-SOD, GPx and vitamin C has been discussed earlier by us [22]. The beneficial effects of SRP on systemic inflammatory [23,24] and OS markers [1,25] have been reported. Further the studies [26,27] have associated periodontal clinical markers to some biochemical inflammatory [26-28] and OS [5,29,30] markers. Some studies [26,27] have shown a positive association between periodontal clinical markers and IL-6, a negative association with IL-10 [31] while others [28,32] couldn’t find any association between them. OS markers like GPx (5), SOD, TAOC (29) and AO potential [33] were also significantly [29] and non-significantly [33] correlated to the periodontal clinical markers. The study by Teles et al. [28] have studied relationship among IL-6, TNF-α, adipokines and vitamin D in serum of CP individuals and reported correlation among serum parameters but no association between them and clinical parameters [28].

Most of the above studies have taken into consideration the average or mean values of the study parameters for their correlation and the subsequent conclusions. However, up to our knowledge, the association between the extent of improvement (relative% change) in the clinical and biochemical parameters has not been reported, that has been endeavored in this study. In the present study the mean relative % change values observed in the CP group for clinical parameters ranged between 14.52% to 38.76% and those for biochemical markers were between-23.51% to 16.12% (Table 3). Among the biochemical parameters, GPx and Vitamin C indicated post treatment higher values compared to the baseline and hence negative values for relative % changes. RBC-SOD and all the clinical parameters showed post treatment lowered values hence positive values for the relative % change. The correlation between clinical parameters and biochemical markers has been displayed in Table 4. The obtained results of this study showed an insignificant (p ≥ 0.05) positive weak association for RBC-SOD with the clinical parameters. The GPx and vitamin C have showed significant (p ≤ 0.05) correlation to PI, PD and GI respectively. Both the biochemical markers (GPx and vitamin C) showed weak negative correlation to other clinical parameters and the values could not reach statistical significance (p ≥ 0.05). Furthermore as demonstrated in the results, among the clinical parameters, PD and CAL relative % change values(14.52% and 20.57% respectively) were lower than those of GI and PI (38.49% and 38.76% respectively). This indicates that SRP and oral hygiene maintenance may prevent plaque and inflammation, but the therapy regime may contribute to lesser extend in periodontal tissue building and gaining attachment level, at least through the conditions prevailed in this study. Oral clinical improvement is reflected in systemic improvement, however compared to clinical parameter biochemical markers showed relatively lowered relative % change values (-23.51% to 16.12% v/s 14.52% to 38.76% (Table 3). This finding may be attributed to the time period of the study (a follow-up after3 months period) as biochemical markers may need longer time to show the equivalent improvement as those of clinical parameters. Furthermore, biochemical markers are in a dynamic state and may also be affected by other physiological conditions, the monitoring of those variations was beyond the scope of the present study. Albeit varying response, it is promising to note that SRP was effective in improving clinical as well as biochemical markers compared to their corresponding baseline values. Also, the extent of improvement (the relative % change) in clinical parameters showed some correlation to the improvement in biochemical markers, although the correlation could not reach statistical significance for all the parameters.


The present study has showed favorable effects of SRP on clinical and biochemical parameters for individuals with chronic periodontitis. The study findings may encourage dental professionals to include SRP as a beneficial tool in their therapy regime not only to lower local inflammation in individuals with periodontitis but also in improving the systemic health of the diseased individuals.

  1. Wei D, Zhang XL, Wang YZ, Yang CX, Chen G (2010) Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J 55: 70-78.
  2. Giustanini D, Donne ID, Tsikas D, Rossi R (2009) Oxidative stress and human diseases: Origin, link, measurement, mechanism and biomarkers. Crit Rev Clin Lab Sci 46: 241-281.
  3. Chapple IL, Mathews J (2007) The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontology 2000 43: 160-232.
  4. D’ Aiuto F, Nibali L, Parker M, Patel K, Suvan J, et al. (2010) Oxidative stress, systemic inflammation and sever periodontitis. J Dent Res 89: 1241-1246.
  5. Tsai CC, Chen HS, Chen SL, Ho YP, Wu YM, et al. (2005) Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 40: 378-384.
  6. Nassir H, Kantarci A, Dyke TEV (2007) Diabetic periodontitis: A model for activated innate immunity and impaired resolution of inflammation. Periodontology 2000 43: 233-244.
  7. Soliman GZ (2008) Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 49: 129-136.
  8. Correa FOB, Goncalves D, Figueredo CM, Gustafsson A, Orrico SRP (2008) The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis. J Periodont 79: 2143-2150.
  9. Chapple ILC, Brock GR, Milward MR (2007) Compromised GCF TAOC in periodontitis: Cause or effect. J Clin Periodontol 34: 103-110.
  10. Sulaiman AEA, Shehadeh RM (2010) Assessment of total antioxidant capacity and use of vitamin C in the treatment of non-smokers with chronic periodontitis. J Periodontol 81: 1547-1554.
  11. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Yamamoto T, et al. (2009) Short term effect of non-surgical periodontal treatment on plasma level of reactive oxygen metabolites in patients with chronic periodontitis. J Periodontol 80: 901-906.
  12. Armitage GC (2004) The complete periodontal examination. Periodontol 34: 22-33.
  13. Loe H, Silness J (1963) Periodontal disease in pregnancy I. Prevalence and Severity. Acta Odontol Scand 21: 533-551.
  14. Silness J, Loe H (1964) Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22: 121-135.
  15. Armitage GC (1999) Development of a classification system for periodontal disease and conditions. Ann Periodontol 4: 1-6.
  16. Woolliams JA, Wiener G, Anderson PH, McMurray CH (1983) Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep. Res Vet Sci 34: 253-256.
  17. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Transl Res J Lab Clin Med 70: 158-169.
  18. Harold V (2005) Practical Clinical Biochemistry, 5th ed, CBS publishers, London pp: 173-176.
  19. Perry DA (2006) Plaque control for the periodontal patient in Carranza’s Clinical Periodontology. 10th edition. Saunders Elsivier St. Louis, pp: 728-748.
  20. Patel SP, Pradeep AR, Chowdhry S (2009) Cervicular fluid levels of plasma glutathione peroxidase (eGPx) in periodontal health and disease. Arch Oral Biol 54: 543-548.
  21. Akalin FA, Toklu E, Renda N (2005) Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Periodontol 32: 238-243.
  22. Aziz AS, Kalekar MG, Benjamin T, Suryakar AN, Prakashan M, et al. (2013) Effect of non-surgical periodontal therapy on some oxidative stress markers in patients with chronic periodontitis: A biochemical study. World J Dent 4: 17-23.
  23. Gani DK, Lakshmi D, Krishnan R, Emmadi P (2009) Evaluation of CRP and interleukins–6 in the peripheral blood of patients with chronic periodontitis. J Indian Soc Periodontol 13: 69-74.
  24. D’Aiuto F, Orlandi M, Gunsolley JC (2013) Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol 40 Suppl 14: S85-105.
  25. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M (2011) Periodontal treatment decreases plasma oxidized LDL level. Clin Oral Investig 15: 953-958.
  26. Fentoglu O, Koroglu BK, Hicyilmaz H, Sert T, Özdem M, et al. (2011) Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 38: 8-16.
  27. Marcaccini AM, Meshiari CA, Sorgi CA, Saraiva MCP, Souza AMD, et al. (2009) Circulating IL-6 and high-sensitivity C-reactive protein decreases after periodontal therapy in otherwise healthy subjects. J Periodontol 80: 594-602.
  28. Teles FR, Teles RP, Martin L, Socransky SS, Haffajee AD (2012) Relationship among IL-6, TNF-α, adipokines, vitamin D and chronic periodontitis. J Periodontol 83: 1183-1191.
  29. Novakovic N, Todorovic T, Rakic M, Milinkovic I, Dozic I, et al. (2014) Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome. J Periodontal Res 49: 129-136.
  30. Wei PF, Ho KY, Ho YP, Wu YM, Yang YH, et al. (2004) The investigation of glutathione peroxidase, lactoferrin, myelo-peroxidase and interleukin-1β in gingival crevicular fluid: Implication for oxidative stress in human periodontal diseases. J Periodontal Res 39: 287-293.
  31. Passoja A, Puijola I, Knuuttila M, Niemelä O, Karttunen R, et al. (2010) Serum levels of interleukin-10 and tumor necrosis factor-α in chronic periodontitis. J Clin Periodontol 37: 881-887.
  32. Goutoudi P, Diza E, Arvanitidou M (2012) Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis. Int J Dent 2012.
  33. Tamaki N, Tomofuji T, Maruyama T, Ekuni D, Yamanaka R, et al. (2008) Relationship between periodontal condition and plasma reactive oxygen metabolites in patient in the maintenance phase of periodontal treatment. J Periodontol 79: 2136-2142.